Joele Frank is handling media for Alder BioPharmaceuticals, which is focused on the development and commercialization of migraine treatments, in its $2B sale to Denmark’s Lundbeck.
 |
The Danish company is offering $18 per-share for Alder, a 79 percent premium over its Sept. 13 closing price on the NASDAQ.
The owner of a portfolio of brain disease therapies will ante up another $2 per-share, if European regulators approve Alder’s next-generation eptinezumab migraine drug. The US Food & Drug Administration is on track to okay the treatment in February.
An estimated 135M people experience migraines annually. They are characterized by recurrent episodes of moderate to severe headaches accompanied by nausea, vomiting and sensitivity to sound and light.
CEO Deborah Dunsire called Alder an excellent strategic fit that leverages Lundbeck’s “specialized commercial expertise in delivering medicines for brain diseases.”
The transaction is expected to wrap up by yearend.
Joele Frank, Wilkinson Brimmer Katcher’s Andy Brimmer, Aura Reinhard and Tanner Kaufman represent Alder, while Stern Investor Relations’ Sarah McCabe works Wall Street for the Bothell, WA-based biopharmaceutical company.
Longacre Square Partners represents Ancora Holdings as it urges the board of Big Yellow Group to conduct a strategic review of the UK’s No. 1 self-storage company.
Kekst CNC handles Getty Images as it begins a prepackaged Chapter 11 reorganization and receives a commitment from Koch Equity Development and the Getty family to invest $533M in the visual content company.
As capital concentrates among established firms, emerging managers must find new ways to earn investor confidence.
Teneo handles True Food Kitchen as the Scottsdale, AZ-based wellness food restaurant chain that counts Oprah Winfrey as a minority investor files for Chapter 11.
FGS Global and Teneo represent Canada’s billionaire Weston family as its Wittington Investments holding company acquires Boots Group, the 177-year-old UK health & beauty retailer, from Sycamore Partners for $8.9B.
